Physician profile
Mohammad Eslami
NPI 1780665786
$5,705.27
in general payments reported to CMS, 2019-2025
13 companies · $951 in 2025
The $951 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,277 · 2021: $101 · 2022: $215 · 2023: $745 · 2024: $2,416 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,096 · Food and Beverage: $2,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,095.96 |
| Food and Beverage | $2,016.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,517.92 | 2023-2025 | Valiant Captivia, Endurant Iis, Hawkone |
| Silk Road Medical, INC. | $1,135.61 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $1,086.97 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Bolton Medical INC | $168.25 | 2024 | Treo Abdominal Stent-Graft System |
| Penumbra, INC. | $148.35 | 2025 | Penumbra System |
| Getinge USA Sales, LLC | $146.17 | 2025 | Flixene |
| Thrombolex, INC. | $126.82 | 2025 | Bashir Endovascular Catheter |
| Janssen Pharmaceuticals, INC | $124.98 | 2024 | Xarelto |
| Cook Medical LLC | $68.91 | 2019 | |
| Ethicon US, LLC | $62.87 | 2025 | Vistaseal |
| Smith+Nephew, INC. | $55.43 | 2024 | Renasys Go V2 Home |
| Medtronic Vascular, INC. | $42.23 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $20.76 | 2025 | Ajovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Eslami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.